Medicare

The Biden administration plans to name the first 10 Medicare drugs subject to price negotiation, while pharmaceutical companies try to block the effort in court.
A lawsuit that PhRMA filed Wednesday is the latest fusillade against one of the presidents biggest domestic achievements.